Table 1 Correlation between Linc-ROR, HNRNPK and DEPDC1 mRNA expression and clinicopathological parameters of HCC patients.

From: RETRACTED ARTICLE: Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression

Parameter

Number (n = 261)

Linc-ROR level

P value

HNRNPK level

P value

DEPDC1 level

P value

Low (n)

High (n)

Low (n)

High (n)

Low (n)

High (n)

Age (years)

<55

87

70

17

0.345

45

42

0.538

57

30

0.295

≥55

174

148

26

97

77

125

49

Gender

Female

86

70

16

0.516

36

50

0.004

50

36

0.004

Male

175

148

27

106

69

132

43

AFP(ng/mL)

<200

189

168

21

0.000

106

83

0.378

140

49

0.013

≥200

72

50

22

36

36

42

30

T stage

T1 or T2

212

174

38

0.189

118

94

0.397

148

64

0.000

T3 or T4

49

44

5

24

25

34

15

N stage

N0 or NX

259

216

43

0.528

141

118

0.900

181

78

0.542

N1

2

2

0

1

1

1

1

M stage

M0 or MX

257

214

43

0.058

139

118

0.405

178

79

0.184

M1

4

4

0

3

1

4

0

G grade

G1or G2

150

127

23

0.563

95

55

0.001

121

29

0.000

G3 or G4

111

91

20

47

64

61

50

TNM stage

I + II

209

171

38

0.136

117

92

0.306

146

63

0.930

III + IV

52

47

5

25

27

36

16

  1. TNM tumor-node-metastasis, AFP a-fetoprotein, DEPDC1 DEP domain containing 1, HNRNPK heterogeneous nuclear ribonucleoprotein K,
  2. HCC hepatocellular carcinoma.
  3. It is statistically significant, that is <0.05.